The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
Abstract
Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our search revealed the use of neuropsychological test batteries other than the MCCB (eg, BACS,23 CANTAB,24 and CSSB25), though their use is somewhat limited in the ongoing trials.”
From Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? (2013) · cites this paper as [23]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617
Methodology Of Frontal And Executive Function
(2004) · Routledge eBooks · doi:10.4324/9780203344187 · Cited by 554
Ruff, R. M., & Parker, S. B. (1993) · Perceptual and Motor Skills · doi:10.2466/pms.1993.76.3c.1219 · Cited by 490
Gold, J. M., Queern, C. A., Iannone, V. N., & Buchanan, R. W. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1944 · Cited by 327
The contribution of neuropsychology to psychiatry
Keefe, R. S. E. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.6 · Cited by 199
Hobart, M., Goldberg, R. W., Bartko, J. J., & Gold, J. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1951 · Cited by 181
Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia
Evins, A. E., Fitzgerald, S. M., Wine, L., Rosselli, R., & GOFF, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.826 · Cited by 172
Friedman, J. I., Adler, D. N., Howanitz, E. M., Harvey, P. D., Brenner, G. H., Temporini, H. D., WHITE, L. E., & Parrella, M. J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01342-7 · Cited by 168
Neuropsychological function in schizophrenia
Nyman, H. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)80803-3 · Cited by 166
Wilk, C. M., Gold, J. M., Bartko, J. J., Dickerson, F., Fenton, W. S., Knable, M. B., RANDOLPH, C. C., & Buchanan, R. W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.838 · Cited by 164
Test-retest reliability of a new form of the auditory verbal learning test (AVLT)
Geffen, G. M., Butterworth, P., & Geffen, L. B. (1994) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(94)90018-3 · Cited by 126
Guanfacine treatment of cognitive impairment in schizophrenia
Friedman, J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00249-4 · Cited by 113
Mattis dementia rating scale: Internal reliability study using a diffusely impaired population
Gardner, R., Fisher, L., Muñoz, S. O., & Empting, L. (1981) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638108403130 · Cited by 106
Keefe, R. S. E., Roitman, S. E. L., & Dupre, R. L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00037-6 · Cited by 94
Cognitive Impairment in Schizophrenia and Implications of Atypical Neuroleptic Treatment
Harvey, P. D., & Keefe, R. S. E. (1997) · CNS Spectrums · doi:10.1017/s1092852900005034 · Cited by 72
Heresco‐Levy, U., Silipo, G. S., & Javitt, D. (1996) · PubMed · Cited by 53
Flagged first, then by citations
2 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Fett, A.-K. J., Viechtbauer, W., Dominguez, M.-D.-G., Penn, D. L., van Os, J., & Krabbendam, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.001 · Cited by 1,833
Identification of separable cognitive factors in schizophrenia
Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304
Howes, O. D., McCutcheon, R. A., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050503 · Cited by 1,187
Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.532 · Cited by 863
Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers
Clementz, B. A., Sweeney, J. A., Hamm, J. P., Ivleva, E. I., Ethridge, L. E., Pearlson, G. D., Keshavan, M. S., & Tamminga, C. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14091200 · Cited by 768
Metadata
- Authors
- Keefe, R.
- Affiliations
- Duke University (US)
- Corresponding author
- Keefe, R
- ORCID
- Keefe, R
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-06-01
- Volume
- 68
- Issue
- 2-3
- Pages
- 283-297
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2008062633
- Cited by
- 1,573
- References
- 27
- Citations by year
- 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- Brief Assessment of Cognition in Schizophrenia, schizophrenia
- MeSH terms
- Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review